Product ID |
CAS Number |
Product Name |
Quantity |
AS-0248 |
30071-93-3 |
3',5'-Bis(trifluoromethyl)acetophenone |
|
AS-2553 |
261763-18-2 |
3-CHLORO-4-(TRIFLUOROMETHOXY)BENZYL BROMIDE |
|
AS-2563 |
1121-79-5 |
3-Chloro-6-methylpyridazine |
|
AS-3060 |
23432-39-5 |
4-HYDROXY-6-METHOXYQUINOLINE |
|
AS-4372 |
1031929-20-0 |
2-Iodo-4-fluorobenzonitrile |
|
AS-4658 |
74204-00-5 |
3-Bromo-5-methylphenol |
|
AS-4662 |
146780-26-9 |
5-CHLORO-2,4-DIFLUOROBENZONITRILE |
|
AS-4979 |
129825-11-2 |
4'-CHLORO-3'-(TRIFLUOROMETHYL)ACETOPHENONE |
|
AS-4987 |
269409-70-3 |
4-Hydroxyphenylboronic acid pinacol ester |
|
AS-5527 |
768-33-2 |
Chlorodimethylphenylsilane |
|
AS-6061 |
5350-41-4 |
Benzyltrimethylammonium bromide |
|
AS-6097 |
319906-45-1 |
7-Bromo-2-iodo-9,9-dimethyl-9H-fluorene |
|
AS-6323 |
36016-38-3 |
tert-Butyl N-hydroxycarbamate |
|
AS-7086 |
57455-06-8 |
3-IODOBENZYL ALCOHOL |
|
AS-7482 |
590371-58-7 |
3-Bromo-2-trifluoromethylpyridine |
|
AS-7750 |
513-35-9 |
2-Methyl-2-butene |
|
AS-7764 |
133046-46-5 |
4-Thiazolecarboxylicacid,2-(trifluoromethyl)-,ethylester(9CI) |
|
AS-7768 |
98130-56-4 |
2-Bromo-4,6-difluorophenol |
|
AS-7792 |
108679-71-6 |
3-AMINO-2-CHLOROBENZOIC ACID |
|
AS-7943 |
1118-90-7 |
L-2-Aminoadipic acid |
|
AS-8255 |
914295-16-2 |
FostaMatinib DisodiuM Hexahydrate |
|
AS-8263 |
79762-54-2 |
6-Bromoindazole |
|
AS-8554 |
1522-92-5 |
3-Bromo-2,2-bis(bromomethyl)propanol |
|
AS-9142 |
81246-82-4 |
5'-DMT-RIBO ADENOSINE (N-BZ) |
|
JR6-L1555 |
1334725-02-8 |
Borate(1-), [2-[(hydroxy-O)methyl]-2-methyl-1,3-propanediolato(3-)-O1,O3](3-methyl-2-pyridinyl)-, lithium (1:1), (T-4)- |
|
JR6-L3815 |
1414976-28-5 |
Benzenemethanamine, N-[[(1R,2R)-2-(1,3-dioxolan-2-yl)cyclopentyl]methyl]- |
|
JR6-L4439 |
252759-90-3 |
3-Pyrrolidinol, 1-(2-nitrophenyl)-, (3S)- |
|
JR6-L4898 |
1360451-37-1 |
Cyclobutanecarbonitrile, 1-[2-bromo-4-(trifluoromethyl)phenyl]- |
|
JR6-L4957 |
124276-45-5 |
Cyclopropanecarbonitrile, 1-(2-chloro-6-fluorophenyl)- |
|
JR6-L6539 |
1368289-38-6 |
2-Benzothiazolamine, 6-ethyl-4-nitro- |
|
|
|
|
|
|
|
|
|
|
|
|
|